An 2 Therapeutics Inc (ANTX)

Finanzdaten der An 2 Therapeutics Inc-Aktie (ANTX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	2.76% 18.30	18.82	18.18	16.60	16.04
Operating Income/Loss	2.76% -18.30	-18.82	-18.18	-16.60	-16.04
Income/Loss From Continuing Operations Before Tax	1.66% -16.62	-16.90	-16.71	-15.80	-15.32
Income/Loss From Continuing Operations After Tax	1.66% -16.62	-16.90	-16.71	-15.80	-15.32
Net Income/Loss	1.66% -16.62	-16.90	-16.71	-15.80	-15.32
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,340% 29.76	2.0676	25.65	19.50	19.39
Diluted Average Shares	1,340% 29.76	2.0676	25.65	19.50	19.39
Basic Earnings Per Share	7.69% -0.56	-0.52	-0.65	-0.81	-0.79
Diluted Earnings Per Share	7.69% -0.56	-0.52	-0.65	-0.81	-0.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-